Biocytogen and Hansoh Pharma announce an antibody license agreement
Biocytogen will provide a license to Hansoh Pharma for their selected fully human antibody molecules
Biocytogen will provide a license to Hansoh Pharma for their selected fully human antibody molecules
The PharmaEssentia Innovation Research Center (PIRC) will advance the company’s diverse pipeline and research footprint in the U.S., driving job creation
Kyfora Bio will focus on the synthesis of cationic polymers, lipids, and other materials used in nucleic acid delivery for cell and gene therapies.
MindRank expects to initiate a Phase I safety study in the first quarter of 2023.
UHI is envisioned as a foundational layer of the Ayushman Bharat Digital Mission and aims to enable interoperability in health services in India through open protocols
The designation recognizes Seeq's expertise in enabling faster insights and better business outcomes for life sciences customers, including Bristol Myers Squibb, with advanced analytics innovations.
He has global experience in strategic and operational leadership including at Board, CEO and Senior Corporate levels
New Lexington, Massachusetts facility to provide customer education and collaboration opportunities
South Asia’s largest exhibition for pharma brought together over 50,000 visitors from across the globe
Subscribe To Our Newsletter & Stay Updated